Tetrahydrofuran → (3-Hydroxymethyl-piperidin-1-yl)-[5-(4-methyl-5-trifluoromethyl-isoxazol-3-yl)-thiophen-2-yl]-methanone

HRID 572301Notes

Reaction equation

HRID 572301 reaction equation
[F:1][C:2]([F:18])([F:17])[C:3]1[O:7][N:6]=[C:5]([C:8]2[S:12][C:11]([C:13]([OH:15])=O)=[CH:10][CH:9]=2)[C:4]=1[CH3:16].[NH:19]1[CH2:24][CH2:23][CH2:22][CH:21]([CH2:25][OH:26])[CH2:20]1.C1COCC1.N1CCCCC1>C(N(CC)CC)C>[OH:26][CH2:25][CH:21]1[CH2:22][CH2:23][CH2:24][N:19]([C:13]([C:11]2[S:12][C:8]([C:5]3[C:4]([CH3:16])=[C:3]([C:2]([F:1])([F:18])[F:17])[O:7][N:6]=3)=[CH:9][CH:10]=2)=[O:15])[CH2:20]1

Participants

6

Procedure

Prepared from 5-(5-Trifluoromethyl-4-methyl-isoxazol-3-yl)-thiophene-2-carboxylic acid and 3-piperidinemethanol by the method described in Example 2 Method B reversing the order of addition such that solid acid chloride was added to a THF solution of triethylamine and piperidine derivative. The reaction mixture was evaporated to an oil then partitioned between EtOAc (5 mL) and water (5 mL). The organic fraction was further washed with brine (2×5 mL), dried over MgSO4, filtered, and evaporated to an oil. The crude product was then chromatographed on silica gel with EtOAc/hexanes (75%) as eluant to (190 mg, 75%). 1H NMR (CDCl3) 1.28-1.35 (m, 1H), 1.44-1.56 (m, 1H), 1.67-1.82 (m, 3H), 2.28 (d, J=0.9, 3H), 2.99 (dd, J=13.2, 9.7, 1H), 3.32 (br s, 1H), 3.41-3.52 (m, 2H), 4.10 (br s, 1H), 4.21 (d, J=11.4, 1H), 7.29 (d, J=4.0, 1H), 7.37 (d, J=4.0, 1H). 13C NMR 7.8, 24.9, 27.2, 39.1, ˜49 (br), 64.5, 114.8, 118.7 (q, J=271), 128.1, 129.3, 131.2, 140.3, 155.0 (q, J=40), 157.9, 162.9. 19F NMR −63.2. LC/MS 5.91 min, [M+1]+ 375.

Workup

  1. customThe reaction mixture was evaporated to an oil
  2. customthen partitioned between EtOAc (5 mL) and water (5 mL)
  3. washThe organic fraction was further washed with brine (2×5 mL)
  4. dry with materialdried over MgSO4
  5. filtrationfiltered
  6. customevaporated to an oil
  7. customThe crude product was then chromatographed on silica gel with EtOAc/hexanes (75%) as eluant to (190 mg, 75%)
  8. customLC/MS 5.91 min, [M+1]+ 375

Sources & evidence

ORD record
ord-e233fcb18ca849a6bafc059ae86065af
Source dataset
uspto-grants-2015_05
Patent number
US09029397B2

Reaction notes

Loading…